81825-0011 NDC - STRESS II (EPINEPHRINE, THYROID, UNSPECIFIED, BOS TAURUS PITUITARY GLAND, POSTERIOR, ARSENIC TRIOXIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, CONIUM MACULATUM FLOWERING TOP, CORTISONE ACETATE, CROTALUS HORRIDUS HORRIDUS VENOM, IRON, STRYCHNOS NUX-VOMICA SEED, PHOSPHORIC ACID, PHOSPHORUS, SELENIUM, SEPIA OFFICINALIS JUICE, AND ZANTHOXYLUM AMERICANUM BARK)

Drug Information

Product NDC: 81825-0011
Proprietary Name: Stress II
Non Proprietary Name: epinephrine, thyroid, unspecified, bos taurus pituitary gland, posterior, arsenic trioxide, oyster shell calcium carbonate, crude, conium maculatum flowering top, cortisone acetate, crotalus horridus horridus venom, iron, strychnos nux-vomica seed, phosphoric acid, phosphorus, selenium, sepia officinalis juice, and zanthoxylum americanum bark
Active Ingredient(s): 12 [hp_X]/mL ARSENIC TRIOXIDE; 9 [hp_X]/mL BOS TAURUS PITUITARY GLAND, POSTERIOR; 12 [hp_X]/mL CONIUM MACULATUM FLOWERING TOP; 12 [hp_X]/mL CORTISONE ACETATE; 12 [hp_X]/mL CROTALUS HORRIDUS HORRIDUS VENOM; 9 [hp_X]/mL EPINEPHRINE; 12 [hp_X]/mL IRON; 12 [hp_X]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 12 [hp_X]/mL PHOSPHORIC ACID; 12 [hp_X]/mL PHOSPHORUS; 12 [hp_X]/mL SELENIUM; 12 [hp_X]/mL SEPIA OFFICINALIS JUICE; 12 [hp_X]/mL STRYCHNOS NUX-VOMICA SEED; 9 [hp_X]/mL THYROID, UNSPECIFIED; 30 [hp_X]/mL ZANTHOXYLUM AMERICANUM BARK
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name	Field Value
Labeler Name:	Zorex
Product Type:	HUMAN OTC DRUG
FDA Application Number:
Marketing Category:	UNAPPROVED HOMEOPATHIC
Start Marketing Date:	6/16/2025

Package Information

No.	Package Code	Package Description	Billing Unit
1	81825-0011-1	30 mL in 1 BOTTLE, DROPPER (81825-0011-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	81825-0011	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	HUMAN OTC DRUG	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAME	Stress II	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAME	epinephrine, thyroid, unspecified, bos taurus pituitary gland, posterior, arsenic trioxide, oyster shell calcium carbonate, crude, conium maculatum flowering top, cortisone acetate, crotalus horridus horridus venom, iron, strychnos nux-vomica seed, phosphoric acid, phosphorus, selenium, sepia officinalis juice, and zanthoxylum americanum bark	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
ROUTE NAME	ORAL	The translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE	6/16/2025	This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAME	UNAPPROVED HOMEOPATHIC	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Zorex	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	ARSENIC TRIOXIDE; BOS TAURUS PITUITARY GLAND, POSTERIOR; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; CROTALUS HORRIDUS HORRIDUS VENOM; EPINEPHRINE; IRON; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PHOSPHORIC ACID; PHOSPHORUS; SELENIUM; SEPIA OFFICINALIS JUICE; STRYCHNOS NUX-VOMICA SEED; THYROID, UNSPECIFIED; ZANTHOXYLUM AMERICANUM BARK	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	12; 9; 12; 12; 12; 9; 12; 12; 12; 12; 12; 12; 12; 9; 30
ACTIVE INGRED UNIT	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
PHARM CLASSES	Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]

Drug Information

Labeler Information

Package Information

NDC Record

Download Record